item management s discussion and analysis of financial condition and results of operations results of operations year ended december  compared to net sales totaled  for the year ended december   an increase of  or over the net sales of  reported for the year ended december  unit sales increased from which is about five times the rate of unit growth in the overall heart valve market 
the company sells to independent distributors with assigned territories generally a specific country or region who in turn sell the valve to a hospital or clinic 
the company sells in us dollars so currency risk is borne by the distributor 
during the exchange rate for many currencies fell in value relative to the us dollar 
in europe  these changes caused a decrease in value for some currencies by as much as 
the consequence of this currency change is the same as a price increase to our distributors 
the company responded in select countries by lowering the dollar price of the valve 
during the company was selling valves in most developed countries and several lesser developed countries ldc s so sales growth came primarily from increased usage in existing markets 
in and each of the previous years  a portion of the sales increase came from opening new markets as well as increased usage within existing markets 
the average selling price of the valve declined from to the average selling price of the valve increased from to given the current strength of the us dollar and the pricing strategies of its competitors the company does not expect to be able to raise prices in prior to january  all sales of valves were to customers outside of the united states 
the company initiated a clinical study of the valve at nine hospitals in the united states in during the study  valves are provided to the hospitals at prices designed to recover some of the costs of the clinical study 
the company may expand the study to six additional hospitals in cost of goods sold increased to  for the year ended december  from  total cost of goods sold for the year ended december  cost of goods sold as a percentage of sales increased from for the year ended december  to for the year ended december   primarily due to lower average selling prices 
the company purchases pyrolytic carbon components for the valve from carbomedics  inc cmi 
approximately of the total cost of a valve is contained in the cost of the carbon components 
the price of the components is set under a multi year supply agreement between the company and cmi 
the price was established in  and varies according to annual volume and is adjusted annually according to increases in the us department of labor employment cost index 
the company uses the first in first out fifo method of accounting for inventory 
approximately of the valves sold in were made with carbon purchased in under fifo and the remainder with carbon purchased in the cost of carbon components  after giving effect to volume discounts and inflationary adjustments rose in the third contract year  decreased 
in  and rose in for the sixth contract year the company expects to pay more for carbon components than in gross profit increased from  for the twelve months ended december  to  for the twelve months ended december  gross profit as a percent of sales was in and in the decrease in the average selling price per unit was the most significant factor in the erosion of the gross margin 
research  development and engineering expenses totaled  for the year ended december  compared to  for the year ended december  during the company completed design and testing on a product extension  the aortic valved graft avg 
this effort accounted for of research and development expense with most of the remainder being spent on the clinical study of the valve 
the company s research efforts in were on improved package design and tooling for valve assembly 
approximately of and of r d expenses related to the clinical study of the valve outside the united states and physical testing of the valve and related consulting to support the company s ide application to the fda 
selling  general and administrative expenses increased from  for the year ended december  to  for the year ended december  this increase resulted from primarily two factors in in october the company closed its facility in scotland and consolidated those operations at its plymouth  minnesota headquarters 
one time costs associated with this closing of approximately  were charged to selling  general and administrative expense in second  the company increased the number of employees from in to in in november  the company sponsored the second international symposium on the ats medical heart valve at an expense of approximately  the company did not have any interest expense in or following the company s million stock sale in february and million warrant exercise in march  the company had substantially more cash  cash equivalents and short term investments earning interest 
interest income in increased to  for the year ended december  compared to  for the year ended december  the company recorded  and  in income tax expense for and  respectively 
these taxes arose from certain items of income in the united kingdom 
net income increased to  for the twelve months ended december  from  for the twelve months ended december  the increase in interest income was the major factor in the increase in net income 
net income per share diluted increased from 
for to 
for weighted average number of shares outstanding increased due to option and warrant exercises  and the sale of shares to itochu corp 
the company has accumulated net operating loss carryforwards in both the us and the uk section of the internal revenue code of  as amended  provides  in part  that if an ownership change occurs with respect to any corporation with net operating loss carryforwards  such as the company  the net operating loss carryforwards can be used to offset future income only to the extent of the annual section limitation 
an ownership change generally occurs if there has been more than a percent change in the stock ownership of a corporation over a three year period 
the section limitation is an amount determined by multiplying the value of the corporation s stock on the date of an ownership change by the federal long term tax exempt rate which is published by the internal revenue service as in effect for the month of the ownership change 
as a result of section  utilization of all or a portion of a corporation s net operating loss carryforwards may be limited 
the company believes that as a result of the company s registered direct equity offering in early and the sale of  shares of common stock in  the company experienced an ownership change  and the company s ability to fully utilize million of its existing net operating loss carryforwards will be restricted to approximately million per year 
due to the application of the annual section limitation and the other provisions of section  some of the net operating loss carryforwards of the company may expire before they can be used by the company to reduce its federal income tax liabilities 
year ended december  compared to net sales totaled  for the year ended december   an increase of  or over the net sales of  reported for the year ended december  unit sales increased overall from during the company s heart valve valve was approved for commercial distribution in japan which accounted for a majority of the sales growth 
an average price increase of was achieved 
cost of goods sold increased to  for the year ended december  from  total cost of goods sold for the year ended december  cost of goods sold as a percentage of sales declined from for the year ended december  to for the year ended december   due to the price increase as well as an increased absorption of overhead which was the result of an approximate increase in unit production 
gross profit increased from  for the twelve months ended december  to  for the twelve months ended december  gross profit as a percent of sales was in and in the increase in the average selling price per unit was the most significant factor in the improvement in the gross margin 
research  development and engineering expenses totaled  for the year ended december  compared to  for the year ended december  the company s research efforts in were on improved package design and tooling for valve assembly 
approximately of and of r d expenses related to the clinical study of the valve outside the united states and physical testing of the valve and related consulting to support the company s ide application for the fda 
selling  general and administrative expenses increased from  for the year ended december  to  for the year ended december  in november the company sponsored the second international symposium on the ats medical heart valve 
this meeting accounted for almost two thirds of the sg a increase with salaries and benefits increases accounting for the remainder 
no equivalent meeting was held in the personnel hired in the sales and marketing department in the middle of were on board for all of the company also had directors and officers liability insurance d o in place from november months and through all of months 
in early  the company borrowed against its line of credit and incurred  of interest expense 
the company did not have any interest expense in interest income in declined to  for the year ended december  compared to  for the year ended december  a decrease in the amount of cash invested and lower market interest rates account for the decline 
the company recorded  and  in income tax expense for and  respectively 
these taxes arose from certain items of income in the united kingdom 
net income increased  from  for the twelve months ended december  to  for the twelve months ended december  the increase in income from operations more than offset the decline in interest income 
this was due to the increased volume of business and the corresponding increase in gross profit 
net income per share increased from 
for to 
for the weighted average number of shares outstanding increased due to option and warrant exercises 
year situation the company has been assessing the software and hardware used in daily operations so that all systems will function properly with respect to dates in the year and beyond 
until recently  computer programs were written to store only two digits of date related information in order to more efficiently handle and store data 
thus  some software programs are unable to distinguish between the year and the year this is frequently referred to as the year problem 
utilizing internal and external resources  the company determined that modification or replacement of various programs would be necessary so that all software  hardware and instrumentation systems are year compliant 
business applications and data for the company are stored on a local area network and accessed by personal computers when necessary 
in  a significant number of employee workstations and manufacturing hardware were upgraded and are now year compliant 
all future hardware purchases are required to be year compliant 
the company has purchased off the shelf manufacturing and accounting software supported by vendors who provide updated versions of the software program 
these vendors have indicated that the software upgrades available will be year compliant 
the company also has custom software programs and databases that are used for manufacturing 
these programs are being reviewed and tested for year issues 
as a part of this process  the company has been negotiating conversion of these programs 
requirements of the software programming include testing and revision for year issues 
while the company believes that its planning efforts are adequate to address year concerns  there is no guarantee that the systems of other companies on which the company s systems and operations rely will be converted on a timely basis and will not have a material effect on the company 
costs of the year initiatives are not expected to be material to the company s results of operations or financial position 
liquidity and capital resources cash  cash equivalents  and short term investments increased by  from  at december  to  at december  inventory increased by  from  at december  to  at december  under the terms of the multi year agreement with carbomedics  inc  the company is required to purchase annual minimum quantities of components 
the minimum number of units which the company purchased during each of the first five years of the contract have exceeded unit sales and the company expects that until the valve is approved for sale in the united states by the fda  the minimum required purchases will continue to exceed sales 
during  the company is obligated to purchase million of heart valve components 
over the two contract years subsequent to  the aggregate purchases total approximately million 
accounts receivable increased by  from  at december  to  at december  most of the company s sales have been to customers in international markets and  while the company attempts to get standard day terms for receivables  competitive pressures and geographical economic situations have caused the company to selectively extend the terms for payment 
accounts receivable represented days sales outstanding dso at december  and dso at december  accounts payable decreased by  from  december  to  at december  in and  the company scheduled the receipt of over of the entire year s components during the fourth quarter 
the decrease in accounts payable at december  is due to timing of component shipments from cmi 
in june the company renewed its line of credit agreement with a bank 
under the agreement  the company may borrow up to  as long as it maintains collateral defined as cash and marketable securities with a discounted value at least equal to the line amount 
the agreement expires on june  there were no borrowings under the line at december  the company received million in cash on february  through the sale of  shares of common stock 
the company expects the obligations under the supply agreement with cmi to require more cash than will be generated by operations through the year during these same years through the company will be conducting a clinical study of the valve in the united states and submitting data obtained from the study to the fda for pre market approval application pma and the opportunity to sell the valve in the united states 
the company estimates that existing cash  cash equivalents and short term investments will be sufficient to satisfy its capital requirements through at least the year the private securities litigation reform act of the act provides a safe harbor for forward looking statements to encourage companies to provide prospective information about their business  so long as those statements are identified as forward looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those discussed in the statement 
ats medical  inc desires to take advantage of the safe harbor provisions with respect to any forward looking statements it may make in this filing  other filings with the securities and exchange commission and any public oral statements or written releases 
the words or phrases will likely  is expected  will continue  is anticipated  estimate  projected  forecast  or similar expressions are intended to identify forward looking statements within the meaning of the act 
such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected 
the company cautions readers not to place undue reliance on any such forward looking statements  which speak only as of the date made 
in accordance with the act  the company identifies the following important general factors which if altered from the current status could cause the company s actual results to differ from those described in any forward looking statements the continued acceptance of the company s only product  a mechanical heart valve in international markets  the acceptance by the fda of the company s regulatory submissions  the continued performance of the company s mechanical heart valve without structural failure  the actions of the company s competitors including pricing changes and new product introductions  the continued performance of the company s independent distributors in selling the valve  and the actions of the company s supplier of pyrolytic carbon components for the valve 
this list is not exhaustive  and the company may supplement this list in any future filing or in connection with the making of any specific forward looking statement 
item a 
quantitative and qualitative disclosures about market risk not applicable 
